European Commission President Ursula von der Leyen has emphasized the EU's commitment to combating cancer, marking World Brain Tumour Day with a call for equitable access to care and accelerated innovation through the Beating Cancer Plan.
In her address, von der Leyen highlighted the alarming statistics surrounding cancer in Europe, noting that approximately 2.7 million new cancer diagnoses occur each year, including 42,000 brain tumor cases. She underscored the importance of prevention, stating that nearly 40% of cancer cases are preventable and advocating for enhanced screening and vaccination efforts, particularly against HPV, which has seen significant uptake in several EU member states.
To facilitate faster treatment development, von der Leyen announced the forthcoming European Biotech Act aimed at streamlining clinical trials and addressing regulatory challenges. Additionally, the European Health Data Space is expected to leverage AI for improved cancer research and treatment, while ensuring privacy standards are upheld. The initiative also seeks to reduce disparities in access to care across different socio-economic groups.
Von der Leyen concluded by emphasizing the need for better support for cancer survivors, advocating for the implementation of the “right to be forgotten” to mitigate discrimination in insurance and lending. This comprehensive approach signifies a pivotal moment in the EU's strategy to transform cancer care and outcomes for millions of patients.